Content Library
2019 Presentations
From Human Genetics To Actionable Targets
Daniel Hoeppner, Astellas
Adjunctive Therapies in the
Treatment of Primary Symptoms
of Schizophrenia
Jim Cassella, Concert Pharmaceuticals
KMO Inhibitors for Depression
Co-Morbid with Chronic Inflammatory Disease
Stevin Zorn, MindImmune Therapeutics
An Overview of Developing PET/SPECT Ligands for CNS Drug Research & Development, An Application of Nuclear Imaging Techniques
Shil Patel, Codiak BioSciences
2018 Presentations
A Circuits and Symptoms Approach to Drug Discovery in Psychiatry
Boehringer Ingelheim
Exploring the gaps in neuropsychiatric research
Lundbeck
The Impact of Genetics on Future Drug Discovery in Psychiatric Disorders
Astellas Pharma